Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
BED Calculator (Biological Effective Dose)DS-GPA Score (Diagnosis-Specific GPA)EQD2 Calculator (Equivalent Dose in 2Gy)GPA Score (Graded Prognostic Assessment)Iso-effective Dose ConverterNSD Calculator (Ellis Formula)RPA Grading for Brain MetastasesRadiation Necrosis MRI IndexSRS Dose Selection (RTOG)TDF Factor (Time-Dose-Fractionation)
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

In Recent Clinical News

Scanning Medical Journals

No new significant updates or guidelines matching this topic were found today. We will check again soon.

Radiation Oncology

Radiation Necrosis MRI Index

Imaging Audit: Necrosis vs Recurrence

MR Perfusion (rCBV)

MR Spectroscopy (Cho/NAA)

Morphology

Imaging Differential

Analyze perfusion and spectroscopy parameters to differentiate post-treatment inflammation from tumor progression.

Guidelines & Evidence

Verified

Last Review: 2026

The Diagnostic Challenge

Pseudoprogression and Necrosis

Radiation necrosis is a delayed inflammatory response to radiation (typically 6–24 months post-treatment) that mimics tumor recurrence on standard contrast-enhanced MRI. Both appear as new or enlarging areas of contrast enhancement with surrounding edema. Accurate differentiation is critical: tumor recurrence requires more treatment (surgery/radiation), while necrosis requires steroids, bevacizumab, or observation.

Advanced Imaging Modalities

ModalityFinding Favoring RecurrenceFinding Favoring Necrosis
MR Perfusion (rCBV)High (rCBV > 2.0)Low (rCBV < 1.0)
MR Spectroscopy (Cho/NAA)High Cho/NAA Ratio (> 1.8)Low Cho/NAA Ratio (< 1.0)
Diffusion (ADC)Low ADC (Highly cellular)High ADC (Necrotic/Fluid)
T1/T2 QuotientHigh (> 0.6)Low (< 0.3)

Last Comprehensive Review: 2026